Position in INVA
as of Jun 30, 2026
· filed Aug 3, 2026
Position Value
$4,942,740
+$4,186,189 QoQ
Shares Held
217,646
+570.3% QoQ
Ownership
0.301%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#52
of 307 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in INVA Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026ENVESTNET ASSET MANAGEMENT INC holds $894,401,954 across 107 Biotechnology names. INVA ranks #32 (0.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
487,627 | $242,218,959 | |
| 2 | REGN |
Regeneron Pharmaceuticals, Inc.
|
109,838 | $68,488,386 | |
| 3 | EXEL |
Exelixis, Inc.
|
949,669 | $51,671,490 | |
| 4 | ARGX |
Argenx SE
|
55,346 | $51,348,358 | |
| 5 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
136,395 | $41,058,986 | |
| 6 | INSM |
INSMED Inc
|
336,997 | $35,930,620 | |
| 7 | RPRX |
Royalty Pharma plc
|
513,096 | $28,769,292 | |
| 8 | ROIV |
Roivant Sciences Ltd.
|
713,946 | $25,266,548 |
All Filings in INVA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $4,942,740 | 217,646 | Shares | Sole | 2026-08-03 | |
| 2026-03-31 | $756,551 | 32,470 | Shares | Sole | 2026-05-04 | |
| 2025-12-31 | $228,385 | 11,425 | Shares | Sole | 2026-02-10 | |
| 2025-09-30 | $239,640 | 13,131 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $201,362 | 10,023 | Shares | Sole | 2025-08-01 | |
| 2025-03-31 | $224,975 | 12,409 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $257,699 | 14,853 | Shares | Sole | 2025-02-13 | |
| 2024-09-30 | $337,828 | 17,495 | Shares | Sole | 2024-11-07 | |
| 2024-06-30 | $246,213 | 15,013 | Shares | Sole | 2024-08-08 | |
| 2023-06-30 | $636,894 | 50,031 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $543,870 | 48,344 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $3,081,632 | 232,576 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $2,376,160 | 204,665 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $3,155,363 | 213,778 | Shares | Sole | 2022-08-03 | |
| 2022-03-31 | $3,752,758 | 193,941 | Shares | Sole | 2022-05-04 | |
| 2021-12-31 | $2,936,295 | 170,220 | Shares | Sole | 2022-02-04 | |
| 2021-09-30 | $2,159,132 | 129,212 | Shares | Sole | 2021-10-07 | |
| 2021-06-30 | $1,495,188 | 111,498 | Shares | Sole | 2021-08-04 | |
| 2021-03-31 | $772,926 | 64,680 | Shares | Sole | 2021-05-04 | |
| 2020-12-31 | $589,664 | 47,592 | Shares | Sole | 2021-02-02 | |
| 2020-09-30 | $574,833 | 55,008 | Shares | Sole | 2020-10-09 | |
| 2020-06-30 | $533,882 | 38,189 | Shares | Sole | 2020-07-08 | |
| 2020-03-31 | $244,619 | 20,801 | Shares | Sole | 2020-04-23 | |
| No filing history on record for this holder in this stock. | ||||||